Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 28Gastric Adenocarcinoma 4Sarcopenia 2Adenocarcinoma 2Recurrence 1Peritoneal Neoplasms 1Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer 1Osteoporosis 1Obesity, Abdominal 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Margins of Excision 1Locally Advanced Gastric Carcinoma 1Locally Advanced Gastric Cancer 1Hypertension 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Diabetes Mellitus 1Coitus 1Advanced Gastric Cancer 1

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Gastrectomy × Clear all
NCT02313688 2017-12-11

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

West China Hospital

Phase NA Unknown
320 enrolled
Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡